Your session is about to expire
← Back to Search
Chemoradiotherapy + Chemotherapy for Gastric Cancer
Study Summary
This trial is investigating whether a shorter course of chemotherapy and radiation treatment followed by standard chemotherapy is effective in treating gastric cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My scans show cancer has spread, but I haven't had or can't have a laparoscopy due to past surgery.I have been diagnosed with stomach cancer through a biopsy.I have health conditions that prevent me from receiving certain cancer treatments.My kidney function is normal or only mildly reduced.My cancer is at least stage T2 or has spread to the lymph nodes.I am not pregnant, will not breastfeed, and will use effective birth control.I've had a severe allergic reaction to chemotherapy before.I can follow the study's requirements and attend all follow-up visits.I have had radiation treatment to the same area before.I can take care of myself and perform daily activities.My cancer has not spread to distant parts of my body according to recent scans.I do not have infections like pneumonia that would stop me from following the treatment plan.I have severe heart problems, including unstable chest pain or heart failure.I have a condition that affects how my body absorbs nutrients.
- Group 1: Treatment (CXRT, chemotherapy, surgery)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research actively seeking participants?
"Clinicaltrials.gov confirms that this medical trial is actively seeking new participants, with the original post date dating to 11 August 2020 and a recent update on 19 August 2020."
To what diseases is Radiation Therapy chiefly administered?
"Radiation Therapy is a viable treatment plan for superficial basal cell carcinoma, rectal carcinoma, and metastatic colorectal carcinoma."
What is the current patient participation rate for this trial?
"Affirmative, the information posted on clinicaltrials.gov suggests that this analysis is currently recruiting participants. The trial began to be advertised on August 11th 2020 and was most recently updated in the same month on the 19th day of August. 30 test subjects are needed from a single site for this investigation."
Has the FDA sanctioned Radiation Therapy?
"Taking into consideration that this is a Phase 1 trial, our team at Power has assigned Radiation Therapy a tentative safety rating of one due to the limited amount of evidence surrounding its efficacy and security."
Have any other research endeavours explored the effectiveness of Radiation Therapy?
"Presently, there are 591 live trials investigating the use of Radiation Therapy with 204 being in Phase 3. Most studies have been conducted out of Adelaide, South Australia but 24807 different sites have hosted such medical research."
Share this study with friends
Copy Link
Messenger